InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Jones Edward Raymond, 董事. Insider active across 1 company, notably Cytosorbents Corp. Aggregated, 3 disclosures have been published. Split: 2 buys · 0 sell. Total volume traded: €13k. History available since 9 December 2021. The latest transaction was filed on 13 December 2023 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Jones Edward Raymond
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
7,519 股@ US$1.3322.1% 占其流量Common StockSEC:0001104659-23-126428:0
标准退出：2024年3月12日 (T+90)
1,676 股@ US$2.236613.1% 占其流量Common StockSEC:0001104659-22-061986:0
标准退出：2022年8月14日 (T+90)
4,000 股@ US$4.12553.1% 占其流量Common StockSEC:0001104659-21-149251:0
3 条申报中的 3 条
About Jones Edward Raymond
Edward Raymond Jones is a Board Member at Cytosorbents Corp. He plays an important role in the governance of the company, bringing his expertise in the medical technology field. His involvement helps Cytosorbents navigate a complex environment and focus on innovation and growth.
